These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 32353955)
1. New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors. Williams KB; Largaespada DA Genes (Basel); 2020 Apr; 11(5):. PubMed ID: 32353955 [TBL] [Abstract][Full Text] [Related]
2. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448 [TBL] [Abstract][Full Text] [Related]
7. p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs. Grit JL; McGee LE; Tovar EA; Essenburg CJ; Wolfrum E; Beddows I; Williams K; Sheridan RTC; Schipper JL; Adams M; Arumugam M; Vander Woude T; Gurunathan S; Field JM; Wulfkuhle J; Petricoin EF; Graveel CR; Steensma MR Oncogene; 2024 May; 43(19):1411-1430. PubMed ID: 38480916 [TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Gottfried ON; Viskochil DH; Couldwell WT Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723 [TBL] [Abstract][Full Text] [Related]
9. MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. Jessen WJ; Miller SJ; Jousma E; Wu J; Rizvi TA; Brundage ME; Eaves D; Widemann B; Kim MO; Dombi E; Sabo J; Hardiman Dudley A; Niwa-Kawakita M; Page GP; Giovannini M; Aronow BJ; Cripe TP; Ratner N J Clin Invest; 2013 Jan; 123(1):340-7. PubMed ID: 23221341 [TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations. Carroll SL; Stonecypher MS J Neuropathol Exp Neurol; 2004 Nov; 63(11):1115-23. PubMed ID: 15581179 [TBL] [Abstract][Full Text] [Related]
11. Genomic Status of Peacock JD; Pridgeon MG; Tovar EA; Essenburg CJ; Bowman M; Madaj Z; Koeman J; Boguslawski EA; Grit J; Dodd RD; Khachaturov V; Cardona DM; Chen M; Kirsch DG; Maina F; Dono R; Winn ME; Graveel CR; Steensma MR Cancer Res; 2018 Jul; 78(13):3672-3687. PubMed ID: 29720369 [TBL] [Abstract][Full Text] [Related]
12. How does the Schwann cell lineage form tumors in NF1? Carroll SL; Ratner N Glia; 2008 Nov; 56(14):1590-1605. PubMed ID: 18803326 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth. Yang K; Guo W; Ren T; Huang Y; Han Y; Zhang H; Zhang J J Exp Clin Cancer Res; 2019 May; 38(1):185. PubMed ID: 31053152 [TBL] [Abstract][Full Text] [Related]
14. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system. Brossier NM; Carroll SL Brain Res Bull; 2012 May; 88(1):58-71. PubMed ID: 21855613 [TBL] [Abstract][Full Text] [Related]
15. Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs. Miller DT; Cortés-Ciriano I; Pillay N; Hirbe AC; Snuderl M; Bui MM; Piculell K; Al-Ibraheemi A; Dickson BC; Hart J; Jones K; Jordan JT; Kim RH; Lindsay D; Nishida Y; Ullrich NJ; Wang X; Park PJ; Flanagan AM Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32252413 [TBL] [Abstract][Full Text] [Related]
16. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis. Luscan A; Shackleford G; Masliah-Planchon J; Laurendeau I; Ortonne N; Varin J; Lallemand F; Leroy K; Dumaine V; Hivelin M; Borderie D; De Raedt T; Valeyrie-Allanore L; Larousserie F; Terris B; Lantieri L; Vidaud M; Vidaud D; Wolkenstein P; Parfait B; Bièche I; Massaad C; Pasmant E Clin Cancer Res; 2014 Jan; 20(2):358-71. PubMed ID: 24218515 [TBL] [Abstract][Full Text] [Related]
17. Neurofibromin Deficiency Causes Epidermal Growth Factor Receptor Upregulation through the Activation of Ras/ERK/SP1 Signaling Pathway in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheet Tumor. Park GH; Lee SJ; Lee CG; Kim J; Park E; Jeong SY Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948100 [TBL] [Abstract][Full Text] [Related]
18. Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor Development. Vélez-Reyes GL; Koes N; Ryu JH; Kaufmann G; Berner M; Weg MT; Wolf NK; Rathe SK; Ratner N; Moriarity BS; Largaespada DA Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808166 [TBL] [Abstract][Full Text] [Related]
20. Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1-associated tumors. Kobayashi D; Hirayama M; Komohara Y; Mizuguchi S; Wilson Morifuji M; Ihn H; Takeya M; Kuramochi A; Araki N J Biol Chem; 2014 Sep; 289(38):26314-26326. PubMed ID: 25092287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]